During the past decade, AccuMed Research Associates conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 23 clinical trials were completed, i.e. on average, 76.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AccuMed Research Associates" #1 sponsor was "Ferring Pharmaceuticals" with 7 trials, followed by "Healthy.io Ltd." with 4 trials sponsored, "Urovant Sciences GmbH" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "GTx" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AccuMed Research Associates" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Bio-Medical Research, Ltd." with 1 trials as a collaborator and "ClinLogix. LLC" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "AccuMed Research Associates" are "Prostate Cancer" (7 trials), "Nocturia" (6 trials), "Overactive Bladder" (5 trials), "Stress Urinary Incontinence" (5 trials) and "Benign Prostatic Hyperplasia" (4 trials). Many other conditions were trialed in "AccuMed Research Associates" in a lesser frequency.

Most popular intervention types in "AccuMed Research Associates" are "Drug" (50 trials), "Device" (8 trials), "Other" (6 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Desmopressin" (3 trials), "GTx-024" (2 trials), "SOV2012-F1" (2 trials) and "TURBT" (2 trials). Other intervention names were less common.

The vast majority of trials in "AccuMed Research Associates" are 32 trials for "Male" genders, 20 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "AccuMed Research Associates". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in AccuMed Research Associates, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in AccuMed Research Associates, 5 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".